192 related articles for article (PubMed ID: 21262387)
21. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
22. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Macedo LF; Guo Z; Tilghman SL; Sabnis GJ; Qiu Y; Brodie A
Cancer Res; 2006 Aug; 66(15):7775-82. PubMed ID: 16885381
[TBL] [Abstract][Full Text] [Related]
23. Local aromatase expression in human prostate is altered in malignancy.
Ellem SJ; Schmitt JF; Pedersen JS; Frydenberg M; Risbridger GP
J Clin Endocrinol Metab; 2004 May; 89(5):2434-41. PubMed ID: 15126575
[TBL] [Abstract][Full Text] [Related]
24. Product of aromatase activity in intact LNCaP and MCF-7 human cancer cells.
Castagnetta LA; Granata OM; Bellavia V; Amodio R; Scaccianoce E; Notarbartolo M; Follari MR; Miceli MD; Carruba G
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):287-92. PubMed ID: 9365203
[TBL] [Abstract][Full Text] [Related]
25. Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.
Murthy S; Marcelli M; Weigel NL
Prostate; 2003 Sep; 56(4):293-304. PubMed ID: 12858358
[TBL] [Abstract][Full Text] [Related]
26. Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, aromatase, estrogen, and androgen activity.
Taxvig C; Elleby A; Sonne-Hansen K; Bonefeld-Jørgensen EC; Vinggaard AM; Lykkesfeldt AE; Nellemann C
Nutr Cancer; 2010; 62(1):122-31. PubMed ID: 20043267
[TBL] [Abstract][Full Text] [Related]
27. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
[TBL] [Abstract][Full Text] [Related]
28. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
29. Aromatase in bone: roles of Vitamin D3 and androgens.
Yanase T; Suzuki S; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):393-7. PubMed ID: 14623536
[TBL] [Abstract][Full Text] [Related]
30. Androgen enhances the antiproliferative activity of vitamin D3 by suppressing 24-hydroxylase expression in LNCaP cells.
Lou YR; Tuohimaa P
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):44-9. PubMed ID: 16524720
[TBL] [Abstract][Full Text] [Related]
31. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts.
Tanaka S; Haji M; Takayanagi R; Tanaka S; Sugioka Y; Nawata H
Endocrinology; 1996 May; 137(5):1860-9. PubMed ID: 8612525
[TBL] [Abstract][Full Text] [Related]
32. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
33. 1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes.
Hughes SV; Robinson E; Bland R; Lewis HM; Stewart PM; Hewison M
Endocrinology; 1997 Sep; 138(9):3711-8. PubMed ID: 9275056
[TBL] [Abstract][Full Text] [Related]
34. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
[TBL] [Abstract][Full Text] [Related]
37. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.
Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O
Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521
[TBL] [Abstract][Full Text] [Related]
38. Aromatase and regulating the estrogen:androgen ratio in the prostate gland.
Ellem SJ; Risbridger GP
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):246-51. PubMed ID: 19896534
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.
Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M
Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712
[TBL] [Abstract][Full Text] [Related]
40. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
